Daniel P. O’Day Salary and Compensation - GILEAD SCIENCES, INC. CEO Pay 2025

In fiscal year 2025, Daniel P. O’Day, Chairman and Chief Executive Officer of GILEAD SCIENCES, INC. (GILD), received total compensation of $28.4 million.

Daniel P. O’Day's compensation breakdown includes: base salary of $1.8 million, stock awards valued at $15.2 million, option awards of $4.5 million, non-equity incentive compensation of $4.8 million, and other compensation of $2.1 million.

Compared to fiscal year 2024, Daniel P. O’Day's total compensation increased 20% from $23.7 million to $28.4 million.

GILEAD SCIENCES, INC. (GILD) Executive Pay 2025

GILEAD SCIENCES, INC.'s top 5 named executive officers received combined total compensation of $65.4 million in fiscal year 2025.

The named executive officers disclosed in GILEAD SCIENCES, INC.'s 2025 proxy statement are:Daniel P. O’Day (Chairman and Chief Executive Officer) with total compensation of $28.4 million, Dietmar Berger (M.D., Ph.D. Chief Medical Officer) with total compensation of $13.9 million, Johanna Mercier (Chief Commercial and Corporate Affairs Officer) with total compensation of $9.3 million, Andrew D. Dickinson (Chief Financial Officer) with total compensation of $8.8 million, and Deborah H. Telman (Former Executive Vice President Corporate Affairs and General Counsel) with total compensation of $5.0 million.